Ignite Creation Date:
2024-05-05 @ 6:30 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00494442
Status:
COMPLETED
Last Update Posted:
2018-08-01
First Post:
2007-06-27
Brief Title:
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca